Sekisui Consolidates Diagnostic Business In China
This article was originally published in PharmAsia News
Executive Summary
Sekisui Chemical March 1 announced a plan to merge two Chinese diagnostic subsidiaries. The move is to increase Chinese market shares and boost efficiency through combined networks